Sequence mutations in teleost cardiac troponin C that are permissive of high Ca 2ϩ affinity of site II MUSCLE CONTRACTION IS INITIATED when membrane depolarization leads to an increase in cytosolic Ca 2ϩ . The binding of Ca 2ϩ to the low-affinity sites of troponin C (TnC) initiates a conformational change in the protein that is transmitted through the other components of the thin filament, allowing cross-bridge cycling between actin and myosin. Many of the characteristic responses of the contractile apparatus can be attributed to the Ca 2ϩ binding properties of TnC. The differences between cardiac and skeletal myofibrils are due, in part, to the structural divergence in the TnC isoforms. While both fast skeletal muscle TnC (sTnC) and cardiac TnC (cTnC) are highly conserved within mammals and between mammals and the chicken, TnC from lower vertebrates exhibits less identity. Thus establishing the links between TnC structure and myofibrillar function should provide insight into both physiological responsiveness and evolutionary origins of contractile regulation.
TnC consists of two globular domains connected by an ␣-helical linker. Both the NH 2 -and COOH-terminal domains contain two EF-hand Ca 2ϩ -binding sites. The COOH-terminal domain possesses two high-affinity sites (III and IV) that are always bound with either Ca 2ϩ or Mg 2ϩ . These sites are considered to be structural sites, helping to anchor TnC into the troponin complex. The two isoforms of TnC that exist in vertebrate striated muscle differ in the number of active Ca 2ϩ -binding sites in the NH 2 -terminal domain. In the isoform of TnC found in fast skeletal muscle (sTnC), both sites I and II are functional, low-affinity Ca 2ϩ -binding sites. In cTnC, which is expressed in both cardiac and slow skeletal muscle, site I is rendered nonfunctional by amino acid substitutions that disrupt its ability to form the pentagonal bipyramid necessary to coordinate Ca 2ϩ . In both isoforms, Ca 2ϩ binding to the NH 2 -terminal site(s) is responsible for triggering contraction (30, 31) . NMR structural studies have demonstrated that the Ca 2ϩ -induced conformational change is greater in sTnC than in cTnC (35) .
Many studies have attempted to assess the impact of the structural differences in TnC isoforms on the functional properties of striated muscle. Ca 2ϩ affinity is very sensitive to pH in cardiac muscle but much less so in skeletal muscle. Studies using transgenic mice (24) and TnC replacement in skinned fibers (7, 25) have demonstrated that TnC isoforms influence the pH sensitivity of striated muscle. Cardiac muscle demonstrates important differences in the length-tension relationship, the basis of the Starling relationship, that have been attributed, at least in part, to cTnC (2, 13) , though there is also compelling evidence to the contrary (22, 26) . Differences in temperature dependence of cardiac and skeletal muscle contractility can also be attributed, in part, to the isoform of TnC that they contain. The Ca 2ϩ affinity of skeletal myofilaments is relatively insensitive to temperature (11, 36) , whereas cardiac muscle becomes desensitized to Ca 2ϩ at low temperatures (5, 6, 14, 16, 37) . Replacement of native cTnC in skinned cardiac muscle with sTnC attenuates this desensitizing effect of temperature (15) . This loss of Ca 2ϩ sensitivity at low temperature has been attributed to a reduction in Ca 2ϩ affinity of cTnC site II (10) . The impact of temperature on myocardial Ca 2ϩ sensitivity is particularly important in cold-blooded animals, such as fish, that experience low and fluctuating environmental temperatures. Functional comparison of cardiac myofibrils from mammals and rainbow trout suggests that trout cardiac muscle has a higher inherent Ca 2ϩ affinity (6) . It is thought that this higher affinity facilitates cardiac function at the low temperatures (0-20°C) normally experienced by this fish (6) . We have demonstrated that the high Ca 2ϩ sensitivity of trout myofibrils is due, in part, to the differences in the affinity of mammalian and trout cTnC for Ca 2ϩ (10) . Although the amino acid sequence of trout cTnC (ScTnC) is 91% identical to mammalian cTnC (McTnC) (27) , and site II is completely conserved, ScTnC has 2.3-fold higher Ca 2ϩ affinity than McTnC at 21°C (10). This difference in affinity was maintained when McTnC and ScTnC Ca 2ϩ binding were compared at 7 and 37°C and over a range of pH values. The comparatively higher Ca 2ϩ affinity of ScTnC would allow for force generation to be initiated at a lower intracellular [Ca 2ϩ ] in the trout myocyte. The purpose of the present study was to identify the residues responsible for interspecies differences in Ca 2ϩ affinity of site II in cTnC. Although all known mammalian cTnC amino acid sequences exhibit 100% identity, there are differences between fish and mammals and within fish species. We created mutants to compare the impact of differences between salmonid (ScTnC) and McTnC. We also exploited naturally occurring differences between trout and Antarctic icefish (40) . Ca 2ϩ binding to site II was measured by titrating the F27W cTnC mutants with Ca 2ϩ while measuring fluorescence. These results demonstrate that there is no difference in the Ca 2ϩ affinity of ScTnC and icefish cTnC (IFcTnC), despite nine amino acid differences. The differences in Ca 2ϩ affinity between mammals and fish can be attributed to amino acid substitutions in the NH 2 -terminal domain, because the removal of the COOH terminus (amino acids 90-161) through the creation of cNTnC mutants maintained the difference in Ca 2ϩ affinity. Gln 29 and Asp 30 were also demonstrated as being required for the higher Ca 2ϩ affinity of ScNTnC.
METHODS
Construction of the IFcTnC F27W mutant. IFcTnC cDNA cloned into PCR2.1-TOPO was first subcloned into the pGex expression vector. To accomplish this, we engineered BamHI and EcoRI restriction sites onto the 5Ј-and 3Ј-ends, respectively, of the IFcTnC cDNA, using Accurase DNA polymerase (DNmp, Farnborough Hants, UK). The sequences of the 5Ј sense oligonucleotide primers used were as follows: BamHI, TCAGGATCCATCGAAGGTCGTATGAACGACATCTACAA-AGCA; EcoRI, GAGTTCATGAAAGGAGTAGAATAAGAAT-TCGCA. After PCR, the product was purified by gel electrophoresis and use of the QIAquick gel extraction kit (Qiagen, Mississauga, ON, Canada) and then digested with BamHI and EcoRI (Pharmacia Biotech, Baie d'Urfé, QC, Canada). pGex plasmid was similarly digested and then ligated with the cassette using T4 DNA ligase (GIBCO BRL, Gaithersburg, MD), and the sequence of the insert was confirmed by sequencing at the Nucleic Acid/Protein Service Unit, University of British Columbia (UBC; Vancouver, BC, Canada) using AmpliTaq dye terminator cycle sequencing.
To substitute Trp for Phe at residue 27, we used the parental plasmid (pGex) containing the wild-type IFcTnC gene insert as a template for the extension of sense and antisense oligonucleotide primers containing a tryptophan point mutation as described in Gillis et al. (10) . The sequence of the 5Ј sense oligonucleotide primer was GCCGCCTTTGA-CATCTGGGTACCAGATGCCGAG. A cassette containing the mutation was made from the mutated plasmid by using the restriction enzymes BamHI and StyI (New England Biolabs, Mississauga, ON, Canada) and was ligated into the similarly digested parental plasmid containing the wild-type IFcTnC gene. The nucleotide sequence of the newly mutated insert was confirmed by sequencing. From this point on, IFcTnC will refer to F27W IFcTnC.
Construction of McNTnC and ScNTnC F27W mutants. To construct McNTnC and ScNTnC F27W mutants, we introduced a stop codon into McTnC and ScTnC cDNA after the Ser codon at residue 89 using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). Both of these gene constructs had been previously mutated to contain the F27W mutation and then cloned into the pGex expression plasmid from Pharmacia Biotech as described in Gillis et al. (10) . These existing parental cDNA inserts were used as templates for the extension of sense and antisense oligonucleotide primers containing the stop codon TAA. The sequences of the 5Ј sense oligonucleotide primers were as follows: ScTnC, GGACGACAGCTAAGGGAAAACAGAGG; McTnC, GGTTCGGTGTATGAAAGATGACAGCTAAGGAA-AAAC. Cassettes containing the mutation were then made using the restriction enzymes StyI and BsmI (New England Biolabs). Full-length F27W ScTnC and McTnC cDNA constructs subcloned into the pGex vector were similarly digested, and the cassette and plasmid were then purified as described above and ligated. The nucleotide sequences of the two newly mutated inserts were confirmed by sequencing. From this point on, McNTnC will refer to F27W McNTnC and ScNTnC will refer to F27W ScNTnC.
Construction of Q29L/D30G ScNTnC, Q29L ScNTnC, D30G ScNTnC, L29Q/G30D McNTnC, and D2N/L29Q/G30D
McNTnC F27W mutants. The cDNA constructs in the pGex plasmid created to synthesize ScNTnC and McNTnC were used as templates for the extension of sense and antisense oligonucleotide primers containing codons to manipulate the residues at positions 29 and 30 using the QuickChange site-directed mutagenesis kit. The sequences of the 5Ј sense oligonucleotide primers used were as follows: Q29L/D30G ScNTnC, GCCTTTGACATCTGGATCCTGGGGGCGGAGG-ACGGC; Q29L ScNTnC, GCCTTTGACATCTGGATCCTGG-ATGCGGAGGACGGC; D30G ScNTnC, GCCTTTGACATCT-GGATCCAGGGGGCGGAGGACGGC; L29Q/G30D McNTnC, GCCTTCGACATCTGGGTGCAGGATGCAGAGGATGGCTGC. Cassettes containing the mutations were made using SmaI (GIBCO BRL) and BsmI and were then ligated into the parental plasmids that had been similarly digested. The nucleotide sequences of the inserts were confirmed by sequencing. Once the sequence of L29Q/G30D McNTnC was confirmed, it was used as a template for the extension of sense and antisense oligonucleotide primers to make the D2N/L29Q/G30D McNTnC mutant. The sequence of the 5Ј sense oligonucleotide primer used to replace the Asp at residue 2 with an Asn was CCATCGAAGGTCGTAT-GAATGACATCTATAAGGCGGC. A cassette containing the mutation was made using BsmI and BamHI and was then ligated into the parental plasmid that had been similarly digested. The nucleotide sequence of the insert was confirmed by sequencing. Expression and purification of cTnC mutants. The pGex plasmids containing the ScNTnC, McNTnC, IFcTnC, Q29L/ D30G ScNTnC, Q29L ScNTnC, D30G ScNTnC, L29Q/G30D McNTnC, and D2N/L29Q/G30D McNTnC inserts were transformed into the Escherichia coli strain BL21 for protein expression. The cTnC mutants were expressed as glutathione S-transferase fusion proteins that were then digested and purified as described previously (10) . The identities of all cTnC mutants were confirmed by NH2-terminal microsequencing and amino acid analysis completed at the Nucleic Acid/Protein Service Unit, UBC. The purities of the isolated proteins as well as their atomic masses were confirmed by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry completed at the UBC Mass Spectrometry Center. Collectively, these tests confirmed the identity of all cTnC mutants.
Solutions used in fluorescence studies. The solution used to measure fluorescence at 21°C, pH 7.0, was identical to that described in Gillis et al. (10) Baudet et al. (3) , was used to confirm the purity and apparent Ca 2ϩ affinity constant (K Ј Ca) of the EGTA used in the solution under the experimental conditions. This electrode was also used to test the initial pCa of the solution and the change in pCa during Ca 2ϩ titration. This electrode was calibrated by using Ca 2ϩ standards (Orion Research, Boston, MA) and was sensitive to a pCa of 8.0. The EGTA had a calculated purity of 95.6% and a K Ј Ca of 2.99 ϫ 10 6 M Ϫ1 . It should be noted that Mg 2ϩ was not included in the reaction buffers despite its physiological presence. The solution composition was carefully considered for simplicity of interpretation of the in vitro experiments as well as accuracy of pCa in the titrations, which were determined as described above.
Fluorescence studies. The fluorescence studies were carried out as previously described (10) using a Photon Technology International (PTI) model C-30 spectrofluorometer (London, ON, Canada) attached to a NesLab (Portsmouth, NJ) water bath to maintain the cuvette at 21.0 Ϯ 0.1°C. Fluorescence was measured during Ca 2ϩ titration of the cTnC mutants by using an excitation wavelength of 276 nm and an emission wavelength of 330 nm. The slit widths for both the excitation and fluorescence light pathways were adjusted to setting 4 on the PTI spectrofluorometer. The relative fluorescence was calculated as the ratio of the fluorescence of the protein and an internal rhodamine standard. The relative fluorescence was calculated as the ratio of the fluorescence of the protein and an internal rhodamine standard. Before the beginning of fluorescence measurements, the current gain setting of each photomultiplier tube (PMT) of the spectrofluorometer was adjusted so that the relative fluorescence of the Ca 2ϩ -saturated cTnC mutants was equal to unity for each mutant.
Data manipulation and statistical analysis. The Ca 2ϩ -dependent component of the fluorescence measurements from each titration was determined by subtracting the fluorescence at basal [Ca 2ϩ ] from all measurements and then expressing the resultant values as percentages of the maximum fluorescence. Each data set was fitted by using the Hill equation with Origin 6.0. (Microcal Software, Northhampton, MA) as previously described (10) . The 2 , which was used as a goodness-of-fit index of the Hill equation to our data, ranged from 0.0017 Ϯ 0.0006 (D30G ScNTnC) to 0.0003 Ϯ 0.00008 (IFcTnC). The effect of the mutations on the K 1 ⁄2 values ([Ca 2ϩ ] at half-maximal fluorescence) determined by the Hill equation curve fitting were analyzed statistically using a one-way repeated measures ANOVA followed by Bonferroni post hoc tests using the statistical software package SigmaStat. The values reported for K1⁄2 are expressed as means Ϯ SE in pCa units. Two means were considered to be significantly different when the P value was Ͻ0.05. (Fig. 1A) . The K 1 ⁄2 of IFcTnC is not significantly different from that previously reported for full-length ScTnC (10) Fig. 2A) , and there were no differences in the K1 ⁄2 values of the two proteins ( Table 1 ). The Hill coefficient is typically used to describe the cooperativity of Ca 2ϩ binding to a single molecule with multiple binding sites (sTnC) or of Ca 2ϩ -activated tension in a functioning myofibril. However, this study determined that in the in vitro Ca 2ϩ binding of cTnC, which has a single activation site, cooperativity is highly unlikely and is reflected in the fact the Hill coefficients were approximately unity for all cTnCs. In these experiments, the Hill coefficient is used only as a parameter of curve fitting, and a physiological interpretation of these relatively small differences has been avoided. The Hill coefficients for the Ca 2ϩ binding curves of McNTnC and Q29L/D30G ScNTnC do not differ, reflecting the similarities in the shape of the Ca 2ϩ binding curves ( (Table 1) .
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Heart rate is determined by many factors, but with each contraction cycle, Ca 2ϩ binds and releases from TnC. If the Ca 2ϩ affinity of TnC is too high, the rate of relaxation will be limited. Thus the cTnC-Ca 2ϩ on-and off-rate constants must be compatible with cardiac performance. Despite the difference of nearly three orders of magnitude in heart rate across birds and mammals, there is very little variation in cTnC primary sequence. Within mammals and between mammals and the chicken, cTnC variation does not seem to be an important determinant of interspecies differences in myocardial contractility. When cTnC structure is compared more widely across vertebrates, a (12, 31) . Examination of the cTnC isoform cloned from another fish, the Antarctic icefish, reveals that there are nine differences in sequence between icefish cTnC and ScTnC. However, of the five sequence differences between ScTnC and McTnC in the NH 2 -terminal domain, three also occur between icefish cTnC and McTnC. These are Asn 2 , Gln 29 , and Asp 30 ( Fig. 3) (40) . In McTnC, the residues at these positions are Asp, Leu, and Gly, respectively (Fig. 3) . The titration curves of IFcTnC and ScTnC are superimposable, and the K 1 ⁄2 values of these curves are similar, demonstrating that the differences in sequence between IFcTnC and ScTnC do not appear to affect Ca 2ϩ affinity. IFcTnC also contains Asn 2 , Gln 29 , and Asp
30
, suggesting that one or a combination of these amino acids is responsible for the high Ca 2ϩ affinity of ScTnC and IFcTnC.
To confirm that sequence differences in the NH 2 -terminal domain of ScTnC are responsible for its higher Ca 2ϩ affinity, we removed the COOH terminus from both ScTnC and McTnC, creating cNTnC mutants. cNTnC mutants have been used in previous studies to examine the structure and Ca 2ϩ activation of the NH 2 -terminal domain (20, 34, 35) . Spyracopoulos et al. (35) have demonstrated that the Ca 2ϩ -saturated NMR solution structure of McNTnC is similar to that of the Ca 2ϩ -saturated NH 2 domain of the full-length mutant (C35S/C84S) chicken cTnC (33) . In the present study, ScNTnC and McNTnC had a higher Ca 2ϩ affin- ity than the respective full-length isoforms. The fact that this difference in affinity was similar for both McNTnC and ScNTnC suggests that any alteration in the ability of site II to bind Ca 2ϩ caused by removal of the COOH-terminal domain was similar for both isoforms.
The difference in affinity between ScNTnC and McNTnC is consistent with that between the fulllength ScTnC and McTnC (10) ( Table 1 ). These data demonstrate that the removal of the COOH terminus of ScTnC and McTnC maintains the difference in affinity between isoforms while removing 8 of the 13 differences in amino acid sequence (Fig. 3) ], however, suggests that the protein, as a result of this mutation, has lost some functional integrity. We have previously observed a similar loss of functionality when the ability of ScTnC to bind Ca 2ϩ was measured at 37°C (10) . Because 37°C is well above the physiological temperature of the protein and lethal to the trout, this result was interpreted as a loss of thermal stability (10) .
The specific mechanism by which the presence of Gln and Asp at residues 29 and 30, respectively, increases the affinity of site II in ScTnC is not known; however, we suggest that it is due to an allosteric effect on the ability of site II to bind Ca 2ϩ . Additionally, through interpretation of 3 (Fig. 3) . The sequence of cTnC cloned from the frog, Xenopus laevis, another ectothermic species, contains Asp at position 2 as in McTnC (41) (Fig. 3) . This suggests that the presence of Asn at residue 2 may be unique only to cTnC cloned from fish and is not a common genotype of ectothermic hearts. To determine whether Asn 2 is required, in addition to Gln 29 Gulati et al. (12) , who demonstrated that the NH 2 -terminal ␣-helical overhang of cTnC, where residue 2 is located, plays a role in regulating the Ca 2ϩ binding characteristics of site II in cTnC.
Fluorescent probes engineered into TnC through Phe to Trp mutation in site I have been used previously to study the Ca 2ϩ binding dynamics of this molecule (8, 19, 21, 27, 29, 32, 38) . We have demonstrated the effectiveness of Trp at residue 27 in reporting Ca 2ϩ binding to site II in McTnC and ScTnC without significantly affecting the ␣-helical content of the protein, which reflects the general structure of the molecule, using far UV circular dichroism spectra (27) . Additionally, the K1⁄2 values of Ca 2ϩ binding to the F27W cNTnC mutants and full-length IFcTnC in the present study are within the range previously reported for that of Ca 2ϩ -triggered tension generation in cardiac myocytes under similar conditions (16, 18, 23, 24, 28, 39) . We therefore maintain that the F27W mutation effec-tively reports on the Ca 2ϩ -induced conformational response of the cTnC isoforms without significantly altering the functional characteristics of the proteins.
We , are required for the high Ca 2ϩ affinity of ScTnC. The identification of these residues represents the focus of future experiments because they represent logical targets for pharmacological intervention to increase the Ca 2ϩ affinity of McTnC to enhance the Ca 2ϩ sensitivity of cardiac tissue. Such an agent would be useful in end-stage heart failure, allowing for increased inotropism and improved stroke volume.
